80%Confidence
0Views
FDASource
2026-04-14Date
Summary
Amneal's tramadol tablets failing impurities specifications at 24-month stability testing reveals potential quality control issues in their manufacturing process. This could affect product shelf life and market confidence in Amneal's extended-release formulations.
Actionable: Evaluate inventory of Amneal tramadol products and consider alternative sources for pain management medications.
AI Confidence: 80%
Data Points
firmAmneal Pharmaceuticals, LLC
classificationClass II
statusOngoing
distributionNationwide within the USA
producttraMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, D
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now